Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs

NCT04980027 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
228
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi